Control of Regulatory T Cell Development by the Transcription Factor Foxp3
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Regulatory T cells engage in the maintenance of immunological self-tolerance by actively suppressing self-reactive lymphocytes. Little is known, however, about the molecular mechanism of their development. Here we show that Foxp3 , which encodes a transcription factor that is genetically defective in an autoimmune and inflammatory syndrome in humans and mice, is specifically expressed in naturally arising CD4 + regulatory T cells. Furthermore, retroviral gene transfer of Foxp3 converts naïve T cells toward a regulatory T cell phenotype similar to that of naturally occurring CD4 + regulatory T cells. Thus, Foxp3 is a key regulatory gene for the development of regulatory T cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Beneficial Treg cell functions are apparent in the uncontrolled inflammation and fatal tissue damage observed in Foxp3 -/- mice 20,21 , a phenotype that can be rescued by transfer of T cells expressing Foxp3 20,21 .”
From Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis (2024) · cites this paper as [21]
In the citing paper
“studies have shown that transfection of T cells with FoxP3 induces regulatory activity.”
From Modulating immune responses to AAV by expanded polyclonal T-regs and capsid specific chimeric antigen receptor T-regulatory cells (2021) · cites this paper as [16]
Citations
Cites
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Self-citationBennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.287 · Cited by 2,639
Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S.-A., Wilkinson, J. E., Galas, D., Ziegler, S. F., & Ramsdell, F. (2001) · Nature Genetics · doi:10.1038/83784 · Cited by 2,636
Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W., & Sakaguchi, S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.303 · Cited by 2,233
Self-citationRead, S., Malmström, V., & Powrie, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.295 · Cited by 2,205
CD4+CD25+ suppressor T cells: more questions than answers
Shevach, E. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri821 · Cited by 2,110
Salomon, B., Lenschow, D. J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A., & Bluestone, J. A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80195-8 · Cited by 2,081
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Research works printed but not linked: 1
- Godfrey V. L., Wilkinson J. E., Russell L. B., Am. J. Pathol. 138, 1379 (1991).
Cited by
Items 401–500 of 1,083
Maker, A. V., Attia, P., & Rosenberg, S. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7746 · Cited by 343
Human FoxP3+ regulatory T cells in systemic autoimmune diseases
Miyara, M., Gorochov, G., Ehrenstein, M., Musset, L., Sakaguchi, S., & Amoura, Z. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.05.004 · Cited by 342
Self-citationTarbell, K. V., Petit, L., Zuo, X., Toy, P., Luo, X., Mqadmi, A., Yang, H., Suthanthiran, M., Mojsov, S., & Steinman, R. M. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061631 · Cited by 342
Transient regulatory T-cells: A state attained by all activated human T-cells
Pillai, V., Ortega, S. B., Wang, C. K., & Karandikar, N. J. (2007) · Clinical Immunology · doi:10.1016/j.clim.2006.10.014 · Cited by 339
Bisikirska, B., Colgan, J., Luban, J., Bluestone, J. A., & Herold, K. C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23961 · Cited by 339
de Ruiter, E. J., Ooft, M. L., Devriese, L. A., & Willems, S. M. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1356148 · Cited by 340
Takimoto, T., Wakabayashi, Y., Sekiya, T., Inoue, N., Morita, R., Ichiyama, K., Takahashi, R., Asakawa, M., Muto, G., Mori, T., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904100 · Cited by 340
Interactions between mesenchymal stem cells and the immune system
Li, N., & Hua, J. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2473-5 · Cited by 338
CD4+FoxP3+ regulatory T cells confer infectious tolerance in a TGF-β–dependent manner
Andersson, J., Tran, D. Q., Pesu, M., Davidson, T. S., Ramsey, H., O'Shea, J. J., & Shevach, E. M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080308 · Cited by 337
Infectious tolerance via the consumption of essential amino acids and mTOR signaling
Cobbold, S. P., Adams, E., Farquhar, C. A., Nolan, K. F., Howie, D., Lui, K. O., Fairchild, P. J., Mellor, A. L., Ron, D., & Waldmann, H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903919106 · Cited by 336
Eos Mediates Foxp3-Dependent Gene Silencing in CD4 + Regulatory T Cells
Pan, F., Yu, H., Dang, E. V., Barbi, J., Pan, X., Grosso, J. F., Jinasena, D., Sharma, S. M., McCadden, E. M., Getnet, D., et al. (2009) · Science · doi:10.1126/science.1176077 · Cited by 334
Frey, D. M., Droeser, R. A., Viehl, C. T., Zlobec, I., Lugli, A., Zingg, U., Oertli, D., Kettelhack, C., Terracciano, L., & Tornillo, L. (2010) · International Journal of Cancer · doi:10.1002/ijc.24989 · Cited by 333
Negative Regulation of T Cell Homeostasis by Lymphocyte Activation Gene-3 (CD223)
Workman, C. J., & Vignali, D. A. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.688 · Cited by 332
Doganci, A., Eigenbrod, T., Krug, N., De Sanctis, G. T., Hausding, M., Erpenbeck, V. J., Haddad, E.-B., Schmitt, E., Bopp, T., Kallen, K.-J., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22433 · Cited by 333
Immunoporosis: Immunology of Osteoporosis—Role of T Cells
Srivastava, R. K., Dar, H. Y., & Mishra, P. K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00657 · Cited by 331
Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer
Ye, L., Zhang, T., Kang, Z., Guo, G., Sun, Y., Lin, K., Huang, Q., Shi, X., Ni, Z., Ding, N., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02368 · Cited by 332
Ladoire, S., Martin, F., & Ghiringhelli, F. (2011) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-1046-y · Cited by 331
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Dai, E., Zhu, Z., Wahed, S., Qu, Z., Storkus, W. J., & Guo, Z. S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01464-x · Cited by 328
Aryl Hydrocarbon Receptor Control of Adaptive Immunity
Quintana, F. J., & Sherr, D. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.113.007823 · Cited by 329
Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells
Palomares, O., Akdis, M., Martín‐Fontecha, M., & Akdis, C. A. (2017) · Immunological Reviews · doi:10.1111/imr.12555 · Cited by 330
Sinicrope, F. A., Rego, R. L., Ansell, S. M., Knutson, K. L., Foster, N. R., & Sargent, D. J. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.053 · Cited by 329
Foxp1 is an essential transcriptional regulator of B cell development
Hu, H., Wang, B., Borde, M., Nardone, J., Maika, S., Allred, L., Tucker, P. W., & Rao, A. (2006) · Nature Immunology · doi:10.1038/ni1358 · Cited by 328
Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease
Paust, S., Lu, L., McCarty, N., & Cantor, H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403342101 · Cited by 328
Bi, J., & Tian, Z. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00760 · Cited by 325
Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease
Coskun, M., Salem, M., Pedersen, J., & Nielsen, O. H. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.06.007 · Cited by 325
PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice
Okazaki, T., Okazaki, I.-M., Wang, J., Sugiura, D., Nakaki, F., Yoshida, T., Kato, Y., Fagarasan, S., Muramatsu, M., Eto, T., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20100466 · Cited by 324
Wang, H. Y., & Wang, R.-F. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.02.004 · Cited by 325
Ravi, R., Noonan, K. A., Pham, V., Bedi, R., Zhavoronkov, A., Ozerov, I. V., Makarev, E., V. Artemov, A., Wysocki, P. T., Mehra, R., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02696-6 · Cited by 325
Targeting the “Cytokine Storm” for Therapeutic Benefit
D'Elia, R. V., Harrison, K., Oyston, P. C., Lukaszewski, R. A., & Clark, G. C. (2013) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00636-12 · Cited by 324
“16 It has been suggested that one Treg cell can influence numerous surrounding cells 486 [102].”
BackgroundHeat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling
Zanin-Zhorov, A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28423 · Cited by 323
RetractedSavage, P. A., Klawon, D. E. J., & Miller, C. H. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-100219-020937 · Cited by 321
Hair follicle immune privilege and its collapse in alopecia areata
Bertolini, M., McElwee, K., Gilhar, A., Bulfone‐Paus, S., & Paus, R. (2020) · Experimental Dermatology · doi:10.1111/exd.14155 · Cited by 318
Immune microenvironments in solid tumors: new targets for therapy
Shiao, S. L., Ganesan, A. P., Rugo, H. S., & Coussens, L. M. (2011) · Genes & Development · doi:10.1101/gad.169029.111 · Cited by 322
Möttönen, M., Heikkinen, J., Mustonen, L., Isomäki, P., Luukkainen, R., & Lassila, O. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02754.x · Cited by 320
Jasper, M. J. (2006) · Molecular Human Reproduction · doi:10.1093/molehr/gal032 · Cited by 320
Oxidative stress in multiple sclerosis: Central and peripheral mode of action
Ohl, K., Tenbrock, K., & Kipp, M. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2015.11.010 · Cited by 317
HTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation In Vivo
Satou, Y., Yasunaga, J.-I., Zhao, T., Yoshida, M., Miyazato, P., Takai, K., Shimizu, K., Ohshima, K., Green, P. L., Ohkura, N., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001274 · Cited by 319
“HBZ inhibits Foxp3-mediated CTLA-4 and GITR expression in CD4+ T cells in vitro In HBZ-Tg mice, the expression of Treg-associated molecules including CTLA-4, GITR and CD25 was suppressed when compared with their expression in Treg cells from non-Tg mice (Figure 3B and E).”
BackgroundResultInfluentialSelf-citationT regulatory cells in atopic dermatitis and subversion of their activity by superantigens
Ou, L.-S., Goleva, E., Hall, C., & Leung, D. Y. M. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.01.772 · Cited by 319
Dendritic cells in the thymus contribute to T-regulatory cell induction
Proietto, A. I., van Dommelen, S., Zhou, P., Rizzitelli, A., D'Amico, A., Steptoe, R. J., Naik, S. H., Lahoud, M. H., Liu, Y., Zheng, P., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810268105 · Cited by 318
van Loosdregt, J., Fleskens, V., Fu, J., Brenkman, A. B., Bekker, C. P. J., Pals, C. E. G. M., Meerding, J., Berkers, C. R., Barbi, J., Gröne, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.018 · Cited by 317
“T cells manipulated to ectopically express Foxp3 acquire the Treg cell phenotype (Khattri et al., 2003; Hori et al., 2003).”
BackgroundMethodInfluentialFranceschini, D., Paroli, M., Francavilla, V., Videtta, M., Morrone, S., Labbadia, G., Cerino, A., Mondelli, M. U., & Barnaba, V. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36604 · Cited by 318
Wieczorek, G., Asemissen, A., Model, F., Turbachova, I., Floess, S., Liebenberg, V., Baron, U., Stauch, D., Kotsch, K., Pratschke, J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2361 · Cited by 317
T-cell Dysfunction in Glioblastoma: Applying a New Framework
Woroniecka, K. I., Rhodin, K. E., Chongsathidkiet, P., Keith, K. A., & Fecci, P. E. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0047 · Cited by 315
Origin and T Cell Receptor Diversity of Foxp3+CD4+CD25+ T Cells
Pacholczyk, R., Ignatowicz, H., Kraj, P., & Ignatowicz, L. (2006) · Immunity · doi:10.1016/j.immuni.2006.05.016 · Cited by 317
Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance
Kallies, A., Hawkins, E. D., Belz, G. T., Metcalf, D., Hommel, M., Corcoran, L. M., Hodgkin, P. D., & Nutt, S. L. (2006) · Nature Immunology · doi:10.1038/ni1321 · Cited by 317
Plasticity of CD4+ FoxP3+ T cells
Zhou, X., Bailey-Bucktrout, S., Jeker, L. T., & Bluestone, J. A. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.007 · Cited by 317
Association of Foxp3 regulatory gene expression with graft-versus-host disease
Miura, Y., Thoburn, C. J., Bright, E. C., Phelps, M. L., Shin, T., Matsui, E. C., Matsui, W. H., Arai, S., Fuchs, E. J., Vogelsang, G. B., et al. (2004) · Blood · doi:10.1182/blood-2004-03-1040 · Cited by 320
Mann, M. K., Maresz, K., Shriver, L. P., Tan, Y., & Dittel, B. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3447 · Cited by 316
A review of the current use of rituximab in autoimmune diseases
Gürcan, H. M., Keskin, D. B., Stern, J. N. H., Nitzberg, M. A., Shekhani, H., & Ahmed, A. R. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2008.10.004 · Cited by 314
Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis
Sekiya, T., Kashiwagi, I., Yoshida, R., Fukaya, T., Morita, R., Kimura, A., Ichinose, H., Metzger, D., Chambon, P., & Yoshimura, A. (2013) · Nature Immunology · doi:10.1038/ni.2520 · Cited by 314
Mechanism of cellular rejection in transplantation
Ingulli, E. (2010) · Pediatric Nephrology · doi:10.1007/s00467-008-1020-x · Cited by 313
Golshayan, D., Jiang, S., Tsang, J., Garin, M. I., Mottet, C., & Lechler, R. I. (2007) · Blood · doi:10.1182/blood-2006-05-025460 · Cited by 313
Robinson, D. S., Larché, M., & Durham, S. R. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423595 · Cited by 313
Stock, P., Akbari, O., Berry, G., Freeman, G. J., DeKruyff, R. H., & Umetsu, D. T. (2004) · Nature Immunology · doi:10.1038/ni1122 · Cited by 313
CCR6 expression defines regulatory effector/memory-like cells within the CD25+CD4+ T-cell subset
Kleinewietfeld, M., Puentes, F., Borsellino, G., Battistini, L., Rötzschke, O., & Falk, K. (2005) · Blood · doi:10.1182/blood-2004-07-2505 · Cited by 312
Banerjee, D. K., Dhodapkar, M. V., Matayeva, E., Steinman, R. M., & Dhodapkar, K. M. (2006) · Blood · doi:10.1182/blood-2006-03-011353 · Cited by 311
Choi, J., Ritchey, J., Prior, J. L., Holt, M., Shannon, W. D., Deych, E., Piwnica-Worms, D. R., & DiPersio, J. F. (2010) · Blood · doi:10.1182/blood-2009-12-257253 · Cited by 309
FANTOM5 CAGE profiles of human and mouse samples
Noguchi, S., Arakawa, T., Fukuda, S., Furuno, M., Hasegawa, A., Hori, F., Ishikawa-Kato, S., Kaida, K., Kaiho, A., Kanamori-Katayama, M., et al. (2017) · Scientific Data · doi:10.1038/sdata.2017.112 · Cited by 310
“Brie fl y, primary cells were purchased as puri fi ed RNAs or frozen cells, or obtained as described previously 19 – 24 through collaboration in the consortium.”
Self-citationRegulation of immunity by self-reactive T cells
Kronenberg, M., & Rudensky, A. (2005) · Nature · doi:10.1038/nature03725 · Cited by 309
Roers, A., Siewe, L., Strittmatter, E., Deckert, M., Schlüter, D., Stenzel, W., Gruber, A. D., Krieg, T., Rajewsky, K., & Müller, W. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041789 · Cited by 308
A bacterial bile acid metabolite modulates Treg activity through the nuclear hormone receptor NR4A1
Li, W., Hang, S., Fang, Y., Bae, S., Zhang, Y., Zhang, M., Wang, G., McCurry, M. D., Bae, M., Paik, D., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.07.013 · Cited by 306
Immune Disorders in Hashimoto’s Thyroiditis: What Do We Know So Far?
Pyzik, A., Grywalska, E., Matyjaszek-Matuszek, B., & Roliński, J. (2015) · Journal of Immunology Research · doi:10.1155/2015/979167 · Cited by 305
“FoxP3 codes scurfin, that is, the negative transcription factor which blocks the expression of proinflammatory cytokines that activate Th1 lymphocytes [40, 41].”
BackgroundSzczepanski, M. J., Szajnik, M., Czystowska, M., Mandapathil, M., Strauss, L., Welsh, A., Foon, K. A., Whiteside, T. L., & Boyiadzis, M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3010 · Cited by 303
CTLA-4 in Regulatory T Cells for Cancer Immunotherapy
Sobhani, N., Tardiel-Cyril, D. R., Davtyan, A., Generali, D., Roudi, R., & Li, Y. (2021) · Cancers · doi:10.3390/cancers13061440 · Cited by 303
Koyama, S., & Nishikawa, H. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002591 · Cited by 305
Interleukin-6 in pregnancy and gestational disorders
Prins, J. R., Gomez-Lopez, N., & Robertson, S. A. (2012) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2012.05.004 · Cited by 301
“The best described subset is the CD4+CD25+ Treg cell subpopulation, which expresses the transcription factor forkhead box P3 (Foxp3) (Fontenot et al., 2003; Hori et al., 2003).”
BackgroundBillerbeck, E., Barry, W. T., Mu, K., Dorner, M., Rice, C. M., & Ploss, A. (2011) · Blood · doi:10.1182/blood-2010-08-301507 · Cited by 304
Immunomodulatory effects of cyclophosphamide and implementations for vaccine design
Sistigu, A., Viaud, S., Chaput, N., Bracci, L., Proietti, E., & Zitvogel, L. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0245-0 · Cited by 305
Hata, H., Sakaguchi, N., Yoshitomi, H., Iwakura, Y., Sekikawa, K., Azuma, Y., Kanai, C., Moriizumi, E., Nomura, T., Nakamura, T., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421795 · Cited by 304
Self-citationPatton, D. T., Garden, O. A., Pearce, W. P., Clough, L. E., Monk, C. R., Leung, E., Rowan, W. C., Sancho, S., Walker, L. S. K., Vanhaesebroeck, B., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.6598 · Cited by 303
Accapezzato, D., Francavilla, V., Paroli, M., Casciaro, M., Chircu, L. V., Cividini, A., Abrignani, S., Mondelli, M. U., & Barnaba, V. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420515 · Cited by 303
Doganci, A., Eigenbrod, T., Krug, N., De Sanctis, G. T., Hausding, M., Erpenbeck, V. J., Haddad, E.-B., Schmitt, E., Bopp, T., Kallen, K.-J., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522433 · Cited by 304
HIV Infection of Naturally Occurring and Genetically Reprogrammed Human Regulatory T-cells
Oswald-Richter, K., Grill, S. M., Shariat, N., Leelawong, M., Sundrud, M. S., Haas, D. W., & Unutmaz, D. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020198 · Cited by 301
FOXP3 Expression and Overall Survival in Breast Cancer
Merlo, A., Casalini, P., Carcangiu, M. L., Malventano, C., Triulzi, T., Mènard, S., Tagliabue, E., & Balsari, A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.9036 · Cited by 301
Tumor-infiltrating T lymphocytes: Friends or foes?
Yu, P., & Fu, Y.-X. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700389 · Cited by 299
Kuroda, N., Mitani, T., Takeda, N., Ishimaru, N., Arakaki, R., Hayashi, Y., Bando, Y., Izumi, K., Takahashi, T., Nomura, T., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.1862 · Cited by 299
Self-citationA multiply redundant genetic switch 'locks in' the transcriptional signature of regulatory T cells
Fu, W., Ergun, A., Lu, T., Hill, J. A., Haxhinasto, S., Fassett, M. S., Gazit, R., Adoro, S., Glimcher, L., Chan, S., et al. (2012) · Nature Immunology · doi:10.1038/ni.2420 · Cited by 296
Immune checkpoint inhibitors in cancer therapy: a focus on T‐regulatory cells
Sasidharan Nair, V., & Elkord, E. (2018) · Immunology & Cell Biology · doi:10.1111/imcb.1003 · Cited by 298
Regulatory T cells in the treatment of disease
Sharabi, A., Tsokos, M. G., Ding, Y., Malek, T. R., Klatzmann, D., & Tsokos, G. C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.148 · Cited by 297
CTLA-4: From mechanism to autoimmune therapy
Hosseini, A., Gharibi, T., Marofi, F., Babaloo, Z., & Baradaran, B. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106221 · Cited by 297
Role of Lymphocytes in Myocardial Injury, Healing, and Remodeling After Myocardial Infarction
Hofmann, U., & Frantz, S. (2015) · Circulation Research · doi:10.1161/circresaha.116.304072 · Cited by 296
“The transcription factor forkhead box P3 (Foxp3) was than identified as a key regulatory gene for the regulatory T cell development, thereby allowing more precise identification of this subset, at least in mice.(15) The development of autoimmune disorders in neonatally thymectomized mice indicated that these cells ori…”
BackgroundZheng, S. G., Wang, J. H., Stohl, W., Kim, K. S., Gray, J. D., & Horwitz, D. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3321 · Cited by 297
Pöllinger, B., Krishnamoorthy, G., Berer, K., Lassmann, H., Bösl, M. R., Dunn, R., Domingues, H. S., Holz, A., Kurschus, F. C., & Wekerle, H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090299 · Cited by 296
Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury
Gandolfo, M. T., Jang, H. R., Bagnasco, S. M., Ko, G.-J., Agreda, P., Satpute, S. R., Crow, M. T., King, L. S., & Rabb, H. (2009) · Kidney International · doi:10.1038/ki.2009.259 · Cited by 295
Knoechel, B., Lohr, J., Kahn, E., Bluestone, J. A., & Abbas, A. K. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050855 · Cited by 296
Tissue regulatory T cells: regulatory chameleons
Muñoz-Rojas, A. R., & Mathis, D. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00519-w · Cited by 281
AP-1 Transcription Factors as Regulators of Immune Responses in Cancer
Atsaves, V., Leventaki, V., Rassidakis, G. Z., & Claret, F. X. (2019) · Cancers · doi:10.3390/cancers11071037 · Cited by 293
Taylor, M. D., LeGoff, L., Harris, A., Malone, E., Allen, J. E., & Maizels, R. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4924 · Cited by 294
Ayyoub, M., Deknuydt, F., Raimbaud, I., Dousset, C., Leveque, L., Bioley, G., & Valmori, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900621106 · Cited by 293
The role of CD28 and cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4) in regulatory T‐cell biology
Sansom, D. M., & Walker, L. S. K. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00419.x · Cited by 293
Plasticity of Human CD4 T Cell Subsets
Geginat, J., Paroni, M., Maglie, S., Alfen, J. S., Kastirr, I., Gruarin, P., De Simone, M., Pagani, M., & Abrignani, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00630 · Cited by 292
Karube, K., Ohshima, K., Tsuchiya, T., Yamaguchi, T., Kawano, R., Suzumiya, J., Utsunomiya, A., Harada, M., & Kikuchi, M. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04999.x · Cited by 292
Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis
Astier, A. L., Meiffren, G., Freeman, S., & Hafler, D. A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29251 · Cited by 292
Regulatory T-cells in autoimmune diseases: Challenges, controversies and—yet—unanswered questions
Grant, C. R., Liberal, R., Mieli-Vergani, G., Vergani, D., & Longhi, M. S. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.10.012 · Cited by 292
“murine Tregs [11-13] and later, in humans, FOXP3 was shown to be expressed predominantly by the CD4 cells expressing the highest level of CD25 [14].”
BackgroundTumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies
Cervantes-Villagrana, R. D., Albores-García, D., Cervantes-Villagrana, A. R., & García-Acevez, S. J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0205-z · Cited by 290
Foxp3: a critical regulator of the development and function of regulatory T cells
Hori, S., & Sakaguchi, S. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.02.020 · Cited by 291
Self-citationLymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis
Cox, A. L., Thompson, S. A. J., Jones, J. L., Robertson, V. H., Hale, G., Waldmann, H., Compston, D. A. S., & Coles, A. J. (2005) · European Journal of Immunology · doi:10.1002/eji.200535075 · Cited by 291
Ishida, T., Ishii, T., Inagaki, A., Yano, H., Komatsu, H., Iida, S., Inagaki, H., & Ueda, R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0261 · Cited by 291
Hirahara, K., Liu, L., Clark, R. A., Yamanaka, K.-I., Fuhlbrigge, R. C., & Kupper, T. S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4488 · Cited by 291
FOXP3+ regulatory T cells and their functional regulation
Li, Z., Li, D., Tsun, A., & Li, B. (2015) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.10 · Cited by 290
Metadata
- Authors
- Hori, S., Nomura, T., & Sakaguchi, S.
- Affiliations
- RIKEN (JP)
- Kyoto University (JP)
- Corresponding author
- Sakaguchi, Shimon
- Venue
- Science
- Published
- 2003-02-14
- Volume
- 299
- Issue
- 5609
- Pages
- 1057-1061
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2002726823
- Cited by
- 8,187
- References
- 31
- Citations by year
- 2026: 178 · 2025: 233 · 2024: 229 · 2023: 220 · 2022: 297 · 2021: 326 · 2020: 320 · 2019: 338 · 2018: 304 · 2017: 324 · 2016: 308 · 2015: 347 · 2014: 384 · 2013: 431 · 2012: 426
- FWCI
- 118.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- regulatory T cells, Foxp3, transcription factors, CD4+ T cells, self-tolerance, T cell suppression, retroviral gene transfer, autoimmune disease, lymphocyte development
- MeSH terms
- Animals, Autoimmune Diseases, DNA-Binding Proteins, Gastritis, Immune Tolerance, Lymphocyte Activation, Mice, Inbred BALB C, Mice, Transgenic, Mutation, Receptors, Antigen, T-Cell, Recombinant Fusion Proteins, T-Lymphocytes, Thymus Gland, Transduction, Genetic, Inflammatory Bowel Diseases, Receptors, Interleukin-2, CD4-Positive T-Lymphocytes, Antigens, CD, T-Lymphocyte Subsets, Cytokines, Mice, SCID, Self Tolerance, T-Lymphocytes, Regulatory, Mice, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.